ARCHBOW CONSULTING NEWS

How Cell and Gene Therapy Companies Can Adapt in an Evolving Commercial Landscape

2021 Health System Specialty Pharmacy Trend Report

How Healthy are Your Pharmaceutical Patient Access Programs?

6 Ways Pharmaceutical Companies Can Adapt to Improve the Chances of Project Success

The Five Data Sets Every Specialty Pharmaceutical Needs Today

Leveraging Hospital Market Research to Impact Future Adoption of Cell and Gene Therapies

Which pharmaceutical HUB design is right for you? Insource vs. Outsource vs. Hybrid.

Track-and-Trace 101

What to know before you migrate a Patient Service Program

Archbow expands cell and gene therapy expertise with newest team member: Paul Furgal

Going global with innovative pharmaceutical contracting and pricing

Why “Demand Chain” is the new “Supply Chain” in Cell and Gene Therapy

5 Steps to Building Your Next Patient Support Services Model

Build a Better Patient

Archbow Consulting opens location in Europe to meet global demand

5 Essential Takeaways from the 2019 regulanet® Conference

Should your FMV be oncology-specific?

Pharma and Biotech Hits and Misses of 2018

Understand your risk: International Pricing Index and Medicare Part B

How low-cost medications succeed in the specialty pharmacy channel